Q² Solutions (IQVIA) Acquires Nexelis from Ampersand Capital Partners
January 10, 2022
Ampersand Capital Partners sold its portfolio company Nexelis to Q² Solutions, a wholly owned subsidiary of IQVIA, Inc. Nexelis, a Laval, Quebec–based provider of assay development and advanced clinical-trial laboratory testing with five operating sites in North America and Europe, will be integrated into IQVIA's global laboratory services to expand capabilities and capacity for vaccine, immunology and other drug-development testing.
- Buyers
- Q² Solutions (a wholly owned subsidiary of IQVIA, Inc.)
- Targets
- Nexelis
- Sellers
- Ampersand Capital Partners
- Industry
- Healthcare Services
- Location
- Quebec, Canada
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.